Serina Therapeutics (SER) EBIT (QoQ) (2018 - 2025)
Serina Therapeutics (SER) EBIT (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Serina Therapeutics | 44.50 Mn | 21.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.89% |
| Sep 30, 2025 | -14.86% |
| Jun 30, 2025 | 5.00% |
| Mar 31, 2025 | -5.57% |
| Dec 31, 2024 | -4.46% |
| Sep 30, 2024 | -37.40% |
| Jun 30, 2024 | -66.57% |
| Mar 31, 2024 | -1,063.07% |
| Dec 31, 2023 | 116.47% |
| Sep 30, 2023 | -54.81% |
| Jun 30, 2023 | 1.77% |
| Mar 31, 2023 | 46.02% |
| Dec 31, 2022 | -14.97% |
| Sep 30, 2022 | 2.58% |
| Jun 30, 2022 | 22.47% |
| Mar 31, 2022 | -9.91% |
| Dec 31, 2021 | -11.53% |
| Sep 30, 2021 | 24.08% |
| Jun 30, 2021 | -0.82% |
| Mar 31, 2021 | 6.02% |